Found 14 matching trials
Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantation (Auto-HSCT) for Newly Diagnosed Diffuse Large B-cell Lymphoma (DLBCL) PHASE2 This study is a prospective, open-label, multicenter study in previously un...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma PHASE3 B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Show More Location
Shandong Provincial Hospital
Learn More & Join Trial
A Study of Orelabrutinib Plus R-CHOP in Treatment-naïve Patients With MCD Subtype Diffuse Large B-cell Lymphoma PHASE3 The purpose of this study is to evaluate the safety and efficacy of orelabr...
Show More Location
The first affiliated hospital of bengbu medical college
Learn More & Join Trial
Genotype-guided Treatment in DLBCL PHASE3 A multicenter, prospective, randomized, open-label, controlled trial to eva...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
CR-CHOP+X in Previously Untreated DEL PHASE2 This is a prospective, single-arm, open-label phase II clinical trial that ...
Show More Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Learn More & Join Trial
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma PHASE3 To evaluate the efficacy of orelabrutinib combined with R-CHOP vs. R-CHOP a...
Show More Location
Anhui Province Cancer Hospital
Learn More & Join Trial
An Ambispective Cohort Study of Orelabrutinib in Combination With Standard Treatment Regimen for Untreated DLBCL N/A To retrospectively collect information on DLBCL patients treated with orela...
Show More Location
Hematological Department, People's Hospital of Jiangsu Province
Learn More & Join Trial
Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma PHASE2 This is a single-center, single-arm, prospective study aimed at evaluating ...
Show More Location
The First Bethune Hospital of Jilin University
Learn More & Join Trial
Orelabrutinib Combined With R-CDOP for DLBCL Patients With High-risk of CNS Relapse Defined by CNS-IPI PHASE2 This is a prospective, multicenter, single-arm clinical study on the treatm...
Show More Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Orelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL. PHASE2 This study aims to explore a new treatment approach for patients with treat...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial